https://www.selleckchem.com/pr....oducts/pf-4708671.ht
en treated with RP for clinically nonmetastatic PCa, high preoperative SII was statistically associated with an increased risk of adverse pathologic features at RP as well as BCR. However, it did not improve the predictive accuracy and clinical value beyond that obtained by current predictive and prognostic models. SII together with a panel of complementary biomarkers is praised to help guide decision-making in clinically nonmetastatic PCa. A 20 year review of health and health care presents the multiple challenges faced by South Afr
Curtir
Comentario
Compartilhar
